Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Zundler

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Cells|August 11, 2023
Adhesion GPCR Gpr126 (Adgrg6) Expression Profiling in Zebrafish, Mouse, and Human KidneySalvador Cazorla-Vázquez, Peter Kösters, Simone Bertz, et al.
Journal of Crohn'S & Colitis|August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammationKatharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
Inflammatory Bowel Diseases|May 23, 2018
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-sMarie-Theres Binder, Emily Becker, Maximilian Wiendl, et al.
Therapeutic Advances in Gastroenterology|July 5, 2022
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitisLaura Besendorf, Tanja M Müller, Carol-Immanuel Geppert, et al.
Frontiers in Medicine|October 26, 2023
Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitisTimo Rath, Raja Atreya, Julia Bodenschatz, et al.
Therapeutic Advances in Gastroenterology|January 2, 2024
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitisFrancesco Vitali, Timo Rath, Entcho Klenske, et al.
Annals of Gastroenterology|November 21, 2024
Paraduodenal pancreatitis as diagnostic challenge: clinical and morphological features of patients with pancreatic pathology involving the pancreatic grooveFrancesco Vitali, Marc Heinrich, Deike Strobel, et al.
United European Gastroenterology Journal|May 29, 2025
IBUS-SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative ColitisSarah Fischer, David Fischmann, Judith Wilde, et al.
Journal of Crohn'S & Colitis|January 20, 2024
Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in VivoSebastian Schramm, Li-Juan Liu, Marek Saad, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Targeting Blimp-1 in T cells results in activation of T-bet-mediated control of immunosuppression in lung cancerSusetta Finotto, Mircea T Chiriac, Susanne Krammer, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Cells|August 11, 2023
Adhesion GPCR Gpr126 (Adgrg6) Expression Profiling in Zebrafish, Mouse, and Human KidneySalvador Cazorla-Vázquez, Peter Kösters, Simone Bertz, et al.
Journal of Crohn'S & Colitis|August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammationKatharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
Inflammatory Bowel Diseases|May 23, 2018
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-sMarie-Theres Binder, Emily Becker, Maximilian Wiendl, et al.
Therapeutic Advances in Gastroenterology|July 5, 2022
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitisLaura Besendorf, Tanja M Müller, Carol-Immanuel Geppert, et al.
Frontiers in Medicine|October 26, 2023
Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitisTimo Rath, Raja Atreya, Julia Bodenschatz, et al.
Therapeutic Advances in Gastroenterology|January 2, 2024
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitisFrancesco Vitali, Timo Rath, Entcho Klenske, et al.
Annals of Gastroenterology|November 21, 2024
Paraduodenal pancreatitis as diagnostic challenge: clinical and morphological features of patients with pancreatic pathology involving the pancreatic grooveFrancesco Vitali, Marc Heinrich, Deike Strobel, et al.
United European Gastroenterology Journal|May 29, 2025
IBUS-SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative ColitisSarah Fischer, David Fischmann, Judith Wilde, et al.
Journal of Crohn'S & Colitis|January 20, 2024
Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in VivoSebastian Schramm, Li-Juan Liu, Marek Saad, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Targeting Blimp-1 in T cells results in activation of T-bet-mediated control of immunosuppression in lung cancerSusetta Finotto, Mircea T Chiriac, Susanne Krammer, et al.
Pageof 10